These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38497412)

  • 1. Biomarkers for predicting atrial fibrillation: An explorative sub-analysis of the randomised SCREEN-AF trial.
    Schmalstieg-Bahr K; Gladstone DJ; Hummers E; Suerbaum J; Healey JS; Zapf A; Köster D; Werhahn SM; Wachter R
    Eur J Gen Pract; 2024 Dec; 30(1):2327367. PubMed ID: 38497412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.
    Büttner P; Schumacher K; Dinov B; Zeynalova S; Sommer P; Bollmann A; Husser D; Hindricks G; Kornej J
    Heart Rhythm; 2018 Aug; 15(8):1132-1137. PubMed ID: 29604419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of mid-regional pro-atrial natriuretic peptide with N-terminal pro B-type natriuretic peptide in the diagnosis of patients with atrial fibrillation and dyspnoea.
    Eckstein J; Potocki M; Murray K; Breidthardt T; Ziller R; Mosimann T; Klima T; Hoeller R; Moehring B; Sou SM; Rubini Gimenez M; Morgenthaler NG; Mueller C
    Heart; 2012 Oct; 98(20):1518-22. PubMed ID: 22865868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
    Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
    Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Atrial Fibrillation Screening According to N-Terminal Pro-B-Type Natriuretic Peptide: A Secondary Analysis of the Randomized LOOP Study.
    Xing LY; Diederichsen SZ; Højberg S; Krieger DW; Graff C; Frikke-Schmidt R; Olesen MS; Brandes A; Køber L; Haugan KJ; Svendsen JH
    Circulation; 2023 Jun; 147(24):1788-1797. PubMed ID: 37061802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation.
    Ellinor PT; Low AF; Patton KK; Shea MA; Macrae CA
    J Am Coll Cardiol; 2005 Jan; 45(1):82-6. PubMed ID: 15629379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial).
    Darkner S; Goetze JP; Chen X; Henningsen K; Pehrson S; Svendsen JH
    Am J Cardiol; 2017 Oct; 120(8):1309-1315. PubMed ID: 28865890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia--the Find-AF study.
    Wachter R; Lahno R; Haase B; Weber-Krüger M; Seegers J; Edelmann F; Wohlfahrt J; Gelbrich G; Görlitz A; Kermer P; Vollmann D; Hasenfuß G; Gröschel K; Stahrenberg R
    PLoS One; 2012; 7(4):e34351. PubMed ID: 22509292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro-B-type natriuretic peptide level at long-term follow-up after atrial fibrillation ablation: a marker of reverse atrial remodelling and successful ablation.
    Solheim E; Off MK; Hoff PI; De Bortoli A; Schuster P; Ohm OJ; Chen J
    J Interv Card Electrophysiol; 2012 Aug; 34(2):129-36. PubMed ID: 21993599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP - A narrative review.
    Kerr B; Brandon L
    Int J Cardiol Heart Vasc; 2022 Dec; 43():101132. PubMed ID: 36246770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Atrial Natriuretic Peptide Value for Predicting Paroxysmal Atrial Fibrillation in Ischemic Stroke Patients.
    Shiroto H; Tomita H; Hagii J; Metoki N; Fujita A; Kamada T; Takahashi K; Saito S; Sasaki S; Hitomi H; Seino S; Baba Y; Uchizawa T; Iwata M; Matsumoto S; Yasujima M; Okumura K
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):772-778. PubMed ID: 27876310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stepwise mass screening for atrial fibrillation using N-terminal pro b-type natriuretic peptide: the STROKESTOP II study design.
    Engdahl J; Svennberg E; Friberg L; Al-Khalili F; Frykman V; Kemp Gudmundsdottir K; Fredriksson T; Rosenqvist M
    Europace; 2017 Feb; 19(2):297-302. PubMed ID: 28011798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Independent effect of atrial fibrillation on natriuretic peptide release.
    Sramko M; Wichterle D; Melenovsky V; Franekova J; Clemens M; Fukunaga M; Kautzner J
    Clin Res Cardiol; 2019 Feb; 108(2):142-149. PubMed ID: 30051184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of left ventricle diastolic function on natriuretic peptides levels in patients with atrial fibrillation.
    Bakowski D; Wozakowska-Kaplon B; Opolski G
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):745-52. PubMed ID: 19545336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M; Van Gelder IC; Van den Berg MP; Boomsma F; Van Veldhuisen DJ
    Europace; 2006 Jul; 8(7):482-7. PubMed ID: 16798760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic performance of three natriuretic peptides in hemodialysis patients: which is the appropriate biomarker?
    Artunc F; Mueller C; Breidthardt T; Twerenbold R; Rettig I; Usta E; Häring HU; Friedrich B
    Kidney Blood Press Res; 2012; 36(1):172-81. PubMed ID: 23108497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative B-Type Natriuretic Peptides to Predict Postoperative Atrial Fibrillation in Cardiac Surgery: A Systematic Review and Meta-Analysis.
    Thet MS; Hlwar KE; Thet KS; Han KPP; Oo AY
    Heart Lung Circ; 2024 Jan; 33(1):23-32. PubMed ID: 38143193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
    Tancin Lambert A; Ratajczak-Tretel B; Al-Ani R; Arntzen K; Bakkejord GK; Bekkeseth HMO; Bjerkeli V; Eldøen G; Gulsvik AK; Halvorsen B; Høie GA; Ihle-Hansen H; Ihle-Hansen H; Ingebrigtsen S; Johansen H; Kremer C; Krogseth SB; Kruuse C; Kurz M; Nakstad I; Novotny V; Naess H; Qazi R; Rezai MK; Rørholt DM; Steffensen LH; Sømark J; Tobro H; Truelsen TC; Wassvik L; AEgidius KL; Pesonen M; de Melis M; Atar D; Aamodt AH;
    Eur J Neurol; 2023 May; 30(5):1352-1363. PubMed ID: 36786305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Baseline Natriuretic Peptides and Atrial Fibrillation Recurrence After Catheter Ablation.
    Zhang Y; Chen A; Song L; Li M; Chen Y; He B
    Int Heart J; 2016; 57(2):183-9. PubMed ID: 26973277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.